Structure‐based identification of binding sites, native ligands and potential inhibitors for G‐protein coupled receptors

G‐protein coupled receptors (GPCRs) are the largest family of cell‐surface receptors involved in signal transmission. Drugs associated with GPCRs represent more than one fourth of the 100 top‐selling drugs and are the targets of more than half of the current therapeutic agents on the market. Our methodology based on the internal coordinate mechanics (ICM) program can accurately identify the ligand‐binding pocket in the currently available crystal structures of seven transmembrane (7TM) proteins [bacteriorhodopsin (BR) and bovine rhodopsin (bRho)]. The binding geometry of the ligand can be accurately predicted by ICM flexible docking with and without the loop regions, a useful finding for GPCR docking because the transmembrane regions are easier to model. We also demonstrate that the native ligand can be identified by flexible docking and scoring in 1.5% and 0.2% (for bRho and BR, respectively) of the best scoring compounds from two different types of compound database. The same procedure can be applied to the database of available chemicals to identify specific GPCR binders. Finally, we demonstrate that even if the sidechain positions in the bRho binding pocket are entirely wrong, their correct conformation can be fully restored with high accuracy (0.28 Å) through the ICM global optimization with and without the ligand present. These binding site adjustments are critical for flexible docking of new ligands to known structures or for docking to GPCR homology models. The ICM docking method has the potential to be used to “de‐orphanize” orphan GPCRs (oGPCRs) and to identify antagonists–agonists for GPCRs if an accurate model (experimentally and computationally validated) of the structure has been constructed or when future crystal structures are determined. Proteins 2003;51:423–433. © 2003 Wiley‐Liss, Inc.

[1]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[2]  Richard Henderson,et al.  A model for the structure of bacteriorhodopsin based on high resolution electron cryomicroscopy , 1990 .

[3]  Karl Edman,et al.  High-resolution X-ray structure of an early intermediate in the bacteriorhodopsin photocycle , 1999, Nature.

[4]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[5]  Three-dimensional Models of α2A-Adrenergic Receptor Complexes Provide a Structural Explanation for Ligand Binding* , 1999, The Journal of Biological Chemistry.

[6]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[7]  K. Jacobson,et al.  Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor. , 1994, European journal of pharmacology.

[8]  P Argos,et al.  Optimal protocol and trajectory visualization for conformational searches of peptides and proteins. , 1992, Journal of molecular biology.

[9]  G Vriend,et al.  Modeling of transmembrane seven helix bundles. , 1993, Protein engineering.

[10]  E. Jacoby,et al.  Modeling of G-protein coupled receptors with bacteriorhodopsin as a template. A novel approach based on interaction energy differences. , 1994, Journal of receptor research.

[11]  R Henderson,et al.  Electron-crystallographic refinement of the structure of bacteriorhodopsin. , 1996, Journal of molecular biology.

[12]  S Schiffmann,et al.  RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. , 1990, Biochemical and biophysical research communications.

[13]  H. Scheraga,et al.  Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides , 1994 .

[14]  J. Baldwin,et al.  Arrangement of rhodopsin transmembrane alpha-helices. , 1997, Nature.

[15]  T. Bleu,et al.  Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5* , 2000, The Journal of Biological Chemistry.

[16]  W. C. Probst,et al.  Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.

[17]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.

[18]  Susumu Goto,et al.  LIGAND: database of chemical compounds and reactions in biological pathways , 2002, Nucleic Acids Res..

[19]  J. Wess,et al.  Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.

[20]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..

[21]  R. Abagyan,et al.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.

[22]  J. Mccammon,et al.  Computational drug design accommodating receptor flexibility: the relaxed complex scheme. , 2002, Journal of the American Chemical Society.

[23]  R. Henderson,et al.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.

[24]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[25]  N. Metropolis,et al.  Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[26]  J. Wess G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Ruben Abagyan,et al.  Ab InitioFolding of Peptides by the Optimal-Bias Monte Carlo Minimization Procedure , 1999 .

[28]  A. Lomize,et al.  The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints. , 1997, Biophysical journal.

[29]  A. Christopoulos Allosteric binding sites on cell-surface receptors: novel targets for drug discovery , 2002, Nature Reviews Drug Discovery.

[30]  Ruben Abagyan,et al.  Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Gebhard F. X. Schertler,et al.  Arrangement of rhodopsin transmembrane α-helices , 1997, Nature.

[32]  Ruben Abagyan,et al.  Derivation of sensitive discrimination potential for virtual ligand screening , 1999, RECOMB.

[33]  B. Wallace,et al.  Modeling and docking the endothelin G-protein-coupled receptor. , 2000, Biophysical journal.

[34]  I. Sylte,et al.  Molecular dynamics of the 5-HT1a receptor and ligands. , 1993, Protein engineering.

[35]  Y. Yatomi,et al.  EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. , 1999, Biochemical and biophysical research communications.

[36]  H Luecke,et al.  Proton transfer pathways in bacteriorhodopsin at 2.3 angstrom resolution. , 1998, Science.

[37]  Patricia H. Reggio,et al.  The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2 , 1999 .

[38]  H. Wikström,et al.  Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT. , 1999, Bioorganic & medicinal chemistry.

[39]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.

[40]  Susumu Goto,et al.  LIGAND database for enzymes, compounds and reactions , 1999, Nucleic Acids Res..

[41]  H. Scheraga,et al.  Monte Carlo-minimization approach to the multiple-minima problem in protein folding. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Ruben Abagyan,et al.  In silico discovery of novel Retinoic Acid Receptor agonist structures , 2001, BMC Structural Biology.

[43]  R Abagyan,et al.  Rational discovery of novel nuclear hormone receptor antagonists , 2000, Proc. Natl. Acad. Sci. USA.

[44]  S. Pyne,et al.  Sphingosine 1-phosphate signalling in mammalian cells. , 2000, The Biochemical journal.

[45]  M. Parmentier,et al.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. , 1991, The EMBO journal.

[46]  G. Mcallister,et al.  Orphan G-protein-coupled receptors and natural ligand discovery. , 2001, Trends in pharmacological sciences.

[47]  H Luecke,et al.  Structure of bacteriorhodopsin at 1.55 A resolution. , 1999, Journal of molecular biology.

[48]  G. Schertler,et al.  Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. , 1995, Biophysical journal.